Mesoblast Financials - Benzinga

Mesoblast Ltd

MESONASDAQ

Trade with Public

Trade with Public

$15.12

-0.36-2.33%

近くで: Sep 25, 5:00 PM EST

$15.21

0.090.6%

時間外: Sep 24, 9:30 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Mesoblast Financials

Mesoblast (MESO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Mesoblast FY EPS $(0.04) Misses $0.01 Estimate, Sales $120.250M Beat $66.000M Estimate

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.01 by 500 percent. This is a 50 percent increase over losses of $(0.09) per share from the same

Benzinga Newsdesk

PRO
Reported Earlier, Mesoblast Reports FY2026 Total Revenue Of $120.3M Up From $17.2M, Net Loss Narrows 44% To $57.5M From $102.1M

Benzinga Newsdesk

PRO
Mesoblast H1 EPS $(0.03) Beats $(0.20) Estimate, Sales $51.342M Miss $72.000M Estimate

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.20) by 84.5 percent. This is a 99.26 percent increase over losses of $(4.20) per share from the same

Benzinga Newsdesk

Earnings Scheduled For February 26, 2026

Benzinga Insights

What's Next: Mesoblast's Earnings Preview

Benzinga Insights

PRO
Mesoblast FY EPS $(0.09) Misses $(0.05) Estimate, Sales $17.20M Up From $5.90M YoY

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 70 percent. This is a 99.05 percent increase over losses of $(8.91) per share from the same

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved